• Es befinden sich keine Produkte im Warenkorb.


Literatur und weiterführende Links (FOOD 42-43)


Abou-Assi S, Craig K, O’Keefe SJ. Hypocaloric jejunal feeding is better than total parenteral nutrition in acute pancreatitis: results of a randomized comparative study. Am J Gastroenterol 2002; 97: 2255–2262.

Abreu MT, Kantorovich V, Vasiliauskas EA, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut. 2004; 53:1129-1136.

Aghdassi E, Wendland E, Steinhard H, et al. Antioxidant vitamin supplemen-tation in Crohn’s disease decreases oxidative stress: a randomized controlled trial. Am J Gastroenterol. 2003; 98:348-353.

Allen ML, Mellow MH, Robinson MG, Orr WC. The effect of raw onions on acid reflux and reflux symptoms. Am. J. Gastroenterol. 1990; 85: 377–380.

Almallah YZ, Ewen SW, El-Tahir A, et al. Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J Clin Immunol. 2000; 20:68-76.

Anti M, Pignataro G, Armuzzi A et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology 1998; 45: 727–732

Babka JC, Castell DO. On the genesis of heartburn – The effects of specific foods on the lower esophageal sphincter. Dig Dis Sci. 1973; 18: 391.

Bamba T,Shimoyama T, Sasaki M et al. Dietary fat attenuates the benefits of an elemental diet in active Crohn’s disease: a randomized, controlled trial.Eur J Gastroenterol Hepatol 2003; 15:151–157.

Beeken WL: Remediable defects in Crohn disease. Arch Intern Med. 1975; 135:686-690.

Bernstein CN, Seeger LL, Anton PA, et al. A randomized, placebocontrolled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther. 1996;10:777–786.

Bhatia V, Tandon RK. Stress and the gastrointestinal tract. J Gastroenterol Hepatol. 2005;20:332–339.

Bischoff SC. Probiotika, Präbiotika. Synbiotika. Thieme, 2009.

Bohles H, Beifuss OJ, Brandl U, et al. Urinary factors of kidney stone formation in patients with Crohn’s disease. Klin Wochenschr. 1988; 66:87-91.

Bousvaros A, Zurakowski D, Duggan C, et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr. 1998; 26:129-135.

Brenner DM, Moeller MJ, Chey WD et al. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 2009; 104: 1033–1049; quiz 1050.

Brignola C, Belloli C, De Simone G, et al. Zinc supplementation restores plasma concentrations of zinc and thymulin in patients with Crohn’s disease. Aliment Pharmacol Ther. 1993; 7:275-280.

Brown L, Devesa S, Chow W. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage and age. J Natl Cancer Inst 2008; 100:1184–1187

Calkins BM: A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34:1841–1854.

Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80(suppl):1717S–1720S.

Card T, Logan RF, Rodrigues LC, Wheeler JG. Antibiotic use and the development of Crohn’s disease. Gut 2004; 53: 246–250.

Cho JH. Inflammatory bowel disease: genetic and epidemiologic considerations. World J Gastroenterol 2008;14: 338–347.

Chowers Y, Sela BA, Holland R, et al. Increased levels of homocysteine in patients with Crohn’s disease are related to folate levels. Am J Gastroenterol. 2000; 95:3498-3502.

Cohen S. Pathogenesis of coffee-induced gastrointestinal symptoms. New Engl J Med. 1980;303:122.

Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.N Engl J Med 1998; 339: 653–658.

Correa P, Piazuelo MB, Camargo MC. The future of gastric cancer prevention. Gastric Cancer. 2004;7:9–16.

Darfeuille-Michaud A, Neut C, Barnich N et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease. Gastroenterology. 1998; 115:1405-1413.

De Silva PS, Olsen A, Christensen J, et al. An association between dietary arachidonic acid, measured in adipose tissue, and ulcerative colitis. Gastroenterology. 2010; 139:1912-1917.

DeLegge M, Alsolaiman MM, Barbour E et al. Short bowel syndrome: parenteral nutrition versus intestinal transplantation. Where are we today? Dig Dis Sci 2007; 52: 876–892.

Den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996; 334:759-762.

Dewar DH, Amato M, Ellis HJ et al. The toxi­city of high molecular weight glutenin subunits of wheat to patients with coeliac disease. Eur J Gas­troenterol Hepatol 2006; 18: 483–49.

Di Stefano M, Veneto G, Malservisi S, et al. Lactose malabsorption and intolerance and peak bone mass. Gastroenterology 2002; 122:1793.

Diculescu M, Ciocirlan M, Ciocirlan M, et al. Folic acid and sulfasalazine for colorectal carcinoma chemoprevention in patients with ulcerative colitis: the old and new evidence. Rom J Gastroenterol. 2003; 12:283-286.

Dray X, Marteau P. The use of enteral nutrition in the management of Crohn’s disease in adults. JPEN J Parenter Enteral Nutr. 2005; 29(suppl):S166-S169.

Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndromes. Surg Clin North Am 1992; 72:445.

Eswaran S, Tack J, Chey WD. Food. the forgotten factor in the irritable bowel syndrome. Gastroenterol Clin North Am. 2011;40:141–162.

Etemad B,Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682–707.

Fernandez-Banares F, Abad-Lacruz A, Xiol X, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol. 1989; 84:744-748.

Fugate SE, Ramsey AM. Resistance to oral vitamin K for reversal of overanticoagulation during Crohn’s disease relapse. J Thromb Thrombolysis. 2004;17:219–223.

Galland L. A new definition of patientcentered medicine. In: Kliger B., Lee R., ed. Integrative Medicine Principles for Practice, New York: McGraw-Hill; 2004:71-104.

Galland L. Magnesium and inflammatory bowel disease. Magnesium 1988; 7:78-83.

Galland L. Nutritional therapy for Crohn’s disease: disease modifying and medication sparing. Altern Ther. 1999; 5:94-95.

Gassull MA. Nutrition and inflammatory bowel disease: its relation to pathophysiology, outcome and therapy. Dig Dis. 2003; 21:220-227.

Gassull MA. The role of nutrition in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther. 2004; 20(suppl 4):79-83.

Geerling BJ, Badart-Smook A, van Deursen C, et al. Nutritional supplemen-tation with n-3 fatty acids and antioxidants in patients with Crohn’s disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis. 2000; 6:77-84.

Gershon M. Nerves, reflexes and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol. 2005;39(suppl 3): S184–S193.

Gibson GR. Dietary modulation of the human gut flora using prebiotics.Br J Nutr. 1998;80:S209–S212.

Gibson PR, Newnham E, Barrett JS, et al. Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther 2007; 25:349.

Glasgow, RE, Mulvihill, SJ.Postgastrectomy syndromes. Probl General Surgery 1997; 14:132.

Goldstein R, Braverman D, Stankiewicz H. Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowelnsyndrome and functional bowel complaints. Isr Med Assoc J 2000; 2: 583–587.

Gonzalez-Huix F, de Leon R, Fernandez-Bañares F, et al. Polymeric enteral diets as primary treatment of active Crohn’s disease: a prospective steroid-controlled trial. Gut. 1993; 34:778-782.

Gorard DA. Enteral nutrition in Crohn’s disease: fat in the formula.Eur J Gastroenterol Hepatol 2003; 15:115–118.

Griffin IJ, Kim SC, Hicks PD, et al. Zinc metabolism in adolescents with Crohn’s disease. Pediatr Res. 2004; 56:235-239.

Griffiths AM. Enteral nutrition in the management of Crohn’s disease. JPEN J Parenter Enteral Nutr. 2005; 29(suppl):S108-S117.

Guyonnet D, Chassany O, Ducrotte P et al. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007; 26: 475–486.

Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27:104-19.

Harries AD, Brown R, Heatley RV, et al. Vitamin D status in Crohn’s disease: association with nutrition and disease activity. Gut. 1985; 26:1197-1203.

Hasler WL. The irritable bowel syndrome. Med Clin North Am. 2002;36:1535–1551.

Heaton KW, Thornton JR, Emmett PM. Treatment of Crohn’s disease with an unrefined-carbohydrate, fiber-rich diet. Br Med J. 1979; 2:764-766.

Hendricks KM, Walker WA: Zinc deficiency in inflammatory bowel disease. Nutr Rev. 1988; 46:401-408.

Hernandez L, Green PH. Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep. 2006;8:383-9.

Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004; 99: 750–759.

Hogan WJ, de Andrade V, Winship DH. Ethanol-induced acute esophageal motor dyspepsia. J Appl Physiol 1972; 32: 755.

Hongisto SM, Paajanen L, Saxelin M et al. A combination of fibre-rich rye bread and yoghurt containing Lactobacillus GG improves bowel function in women with self-reported constipation. Eur J Clin Nutr 2006; 60: 319–324.

Hunter JO, Tuffnell Q, Lee AJ. Controlled trial of oligofructose in the management of irritable bowel syndrome. J Nutr. 1999;129(suppl): 1451S–1453S.

IBD in EPIC Study Investigators, Tjonneland A, Overvad K, Bergmann MM, et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009; 58:1606-1611.

Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J. Am. Coll. Nutr.2003; 22: 56–63.

Isolauri E, Rautava S, Kalliomaki M. Food allergy in irritable bowel syndrome: new facts and old fallacies. Gut. 2004;53:1391–1393.

Janczewska I, Bartnik W, Butruk E, et al. Metabolism of vitamin A in inflammatory bowel disease. Hepatogastroenterology. 1991; 38:391-395.

Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol. 2010; 105:2195-2201.

John S, Luben R, Shrestha SS, et al. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol. 2010; 22:602-606.

Jørgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn’s disease: a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther. 2010; 32:377-383.

Joseph F, Rosenberg AJ. Identifying lactose malabsorbers through breath hydrogen measurements.Lab Med 1986; 17:85.

Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004; 53:1479-1484.

Kahl S, Malfertheiner P. Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol 2004; 18: 947–955.

Kato K, Mizuno S, Umesaki Y, Ishii Y, Sugitani M, Imaoka A, Otsuka M, Hasunuma O, Kurihara R, Iwasaki A, Arakawa Y. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment.Pharmacol.Ther. 20 (2004) 1133–1141.

Kaufmann SE, Kaye MD. Induction of gastro-esophageal reflux by alcohol. Gut 1978; 19; 336.

Khoshoo V, Reifen R, Neuman MG et al. Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn’s disease.JPEN J Parenter Enteral Nutr 1996; 20:401–405.

Kirk GR, White JS, McKie L, Stevenson M, Young I, Clements WD, Rowlands BJ. Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis. J Gastrointest Surg. 2006;10:499-503.

Knight C, El-Matary W, Spray C, Sandhu BK. Long-term outcome of nutritional therapy in paediatric Crohn’s disease. Clin Nutr. 2005; 24:775-779.

Kobayashi M, Tsubono Y, Sasazuki S, Sasaki S, Tsugane S. Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC Study Cohort I. Int J Cancer. 2002;102: 39–44.

Koebnick C, Wagner I, Leitzmann P et al. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 2003; 17: 655–659.

Krasinski SD, Russell RM, Furie B, et al. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders. Am J Clin Nutr. 1985; 41:639-643.

Kumar N, Kumar A, Broor SL, Vij JC, Aanand BS. Effect of milk on patients with duodenal ulcers. Brit Med J 1986;293:666.

Lackner JM, Gudleski GD, Blanchard EB. Beyond abuse: the association among parenting style, abdominal pain, and somatization in IBS patients. Behav Res Ther. 2004;42:41–56.

Lacy BE, Lee RD. Irritable bowel syndrome: a syndrome in evolution. J Clin Gastroenterol. 2005;39(suppl 3):S230–S242.

Lashner BA, Provencher KS, Seidner DL, et al. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis: a case-control study. Gastroenterology. 1989; 97:255-259.

Liedman B, Henningsson A, Mellström D et al. Changes in bone metabolism and body composition after total gastrectomy. results of a longitudinal study. Dig Dis Sci 2000; 45: 819–824.

Lin HC. Small intestinal bacterial overgrowth: a framework for understanding IBS. JAMA. 2004;292:852–858.

Lionetti P, Callegari ML, Ferrari S, et al. Enteral nutrition and microflora in pediatric Crohn’s disease. JPEN J Parenter Enteral Nutr. 2005; 29(suppl):S173-S175.

Loeschke K, König A, Trebert Haeberlin S, Lux F. Low blood selenium concentration in Crohn disease. Ann Intern Med. 1987;106:908.

Loeschke K, Ueberschaer B, Pietsch A, et al. n-3 Fatty acids retard early relapse in ulcerative colitis in remission. Dig Dis Sci. 1996; 41:2087-2094.

Logan EC, Williamson LM, Ryrie DR. Sulphasalazine associated pancytopenia may be caused by acute folate deficiency. Gut. 1986; 27:868-872.

Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480-91.

Loyd DA, Borda IT. Food induced heartburn: Effect of osmolality. Gastroenterology 1981; 80: 740.

Madsen T, Wallin L, Boesby S, Larson H. Esophageal peristalsis in normal subjects. – Influence of pH and volume during imitated gastroesophageal reflux. Scand. J. Gastroent. 1983; 18: 513.

Magee EA, Richardson CJ, Hughes R, Cummings JH. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr.2000; 72:1488-1494.

Malhotra SL. A comparison of unrefined wheat and rice diets in the management of duodenal ulcer. Postgrad. Med. J. 1978;54: 6–9.

Malinen E, Rinttila T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol. 2005;100:373–382.

Manz M, Meier R. Pharmacologic treatments of transit disorders. Ther Umsch 2007; 64: 227–232.

Marotta RB, Floch MH. Diet and nutrition in ulcer disease. Med Clin North Am. 1991;75:967-79.

Martini GA, Brandes JW. Increased consumption of refined carbohydrates in patients with Crohn’s disease. Klin Wochenschr. 1976; 54:367-371.

Mason JB. Folate, colitis, dysplasia, and cancer. Nutr Rev. 1989; 47:314-317.

Matarese LE, Steiger E. Dietary and medical management of short bowel syndrome in adult patients. J Clin Gastroenterol 2006; 40: S85–S93

Matsui T, Iida M, Fujishima M, et al. Increased sugar consumption in Japanese patients with Crohn’s disease. Gastroenterol Jpn. 1990; 25:271.

Mayberry JF, Rhodfes J, Newcombe RC. Increased sugar consumption in Crohn’s disease. Digestion. 1980; 20:323-326.

Mayer EM, Grabowski CJ, Fisher RS. Effects of greater doses of alcohol upon esophageal motor function. Gastroenterology 1978; 75: 1133.

McEligot AJ, Gilpin EA, Rock CL et al. High dietary fiber consumption is not associated with gastrointestinal discomfort in a diet intervention trial. J Am Diet Assoc 2002; 102: 549–551.

Meier R, Beglinger C, Layer P et al. ESPEN guidelines on nutrition in acute pancreatitis.Clin Nutr 2002; 21: 173–183

Middleton SJ, Rucker JT, Kirby GA, et al. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn’s disease. Clin Nutr. 1995; 14:229-236.

Mihaylov S, Stark C, McColl E et al. Stepped treatment of older adults on laxatives. The STOOL trial. Health Technol Assess 2008; 12: 1–160.

Miller AR, North CS, Clouse RE et al. The association of irritable bowel syndrome and somatization disorder. Ann Clin Psychiatry 2001; 13: 25–30

Mirbagheri SA, Nezami BG, Assa S, Hajimahmoodi M. Rectal administration of d-alpha tocopherol for active ulcerative colitis: a preliminary report. World J Gastroenterol. 2008; 14:5990-5995.

Moayyedi P, Ford AC, Talley NJ et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59: 325–332

Mössner J,Keim V, Niederau C, Büchler M, Singer MV, Lankisch P,Göke B. Leitlinien zur Therapie der chronischen Pankreatitis. Z Gastroenterol 1998; 36: 359–367.

Mössner J. Palliation of pain in chronic pancreatitis: use of enzymes. Surg Clin North Am 1999; 79: 861–872.

Muller-Lissner SA, Kamm MA, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005; 100: 232–242.

Murphy DW, Castell DO. Chocolate and heartburn: Evidence on increased esophageal acid exposure after chocolate ingestion. Amer J Gastroent. 1988; 83: 633.

Nebel OT, Castell DO. Inhibition of the lower esophageal sphincter by fat – a mechanism for fatty food intolerance. Gut 1973; 14:270.

Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001; 13: 1143–1147.

Nieves R, Jackson RT. Specific carbohydrate diet in treatment of inflammatory bowel disease. Tenn Med. 2004; 97:407.

Nightingale J, Woodward JM on behalf of the Small Bowel and Nutrition Committee of the British Society of Gastroenterology.Guidelines for the management of patients with a short bowel. Gut 2006; 55: iv1–iv12.

Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. J. Amer. Med. Ass. 2003; 290: 66–72.

Nobaek S, Johansson ML, Molin G et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. AmJ Gastroenterol 2000; 95: 1231–1238.

Norrby S, Sjodahl R, Tagesson C. Ineffectiveness of vitamin A therapy in severe Crohn’s disease. Acta Chir Scand. 1985; 151:465-468.

Nutrition and gut immunity. Fukatsu K, Kudsk KA. Surg Clin North Am. 2011;91:755-70.

O’Keefe SJD, Buchman AL, Fishbein TM et al. Short bowel syndrome and intestinal failure: con­sensus definition and overview. Clin Gastroenterol Hepatol 2006; 4: 6–10.

Ockenga J, Borchert K, Rifal K, et al. Effect of glutamine-enriched total parenteral nutrition in patients with acute pancreatitis. Clin Nutr 2002;21:409–16.

Olafsdottir LB, Gudjonsson H, Jonsdottir HH, et al. Stability of the irritable bowel syndrome and subgroups as measured by three diagnostic criteria. a 10-year follow-up study. Aliment Pharmacol Ther. 2010;32:670–680.

Olah A, Belagyi A, Issekutz M, et al. Randomized clinical trial of specific Lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. BJM 2002;89:1103–7.

Olah A, Belagyi T, Poto L, et al. Symbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double-blind study. Hepatogastoenterology 2007;54:590–4.

Oldenburg B, Koningsberger JC, Van Berge Henegouwen GP, et al: Iron and inflammatory bowel disease. Aliment Pharmacol Ther. 2001; 15:429-438.

Parisi GC, Zilli M, Miani MP et al. High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): amulticenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG). Dig Dis Sci 2002; 47: 1697–1704.

Parry S, Forgacs I. Intestinal infection and irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2005;17:5–9.

Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–31.

Pearce CB, Sadek SA, Walters A, et al.Adouble-blind, randomized, controlled trial to study the effects of an enteral feed supplemented with glutamine, arginine, and omega-3 fatty acid in predicted acute severe pancreatitis. J Pancreas 2006;7:694-71.

Pehl C, Pfeiffer A, Wendl B, Kaess H. The effect of decaffeination of coffee on gastrooesophageal reflux in patients with reflux disease. Aliment Pharmacol Ther 1997; 11: 483–486.

Penix LP. Ischemic strokes secondary to vitamin B12 deficiency–induced hyperhomocystinemia. Neurology. 1998; 51:622-624.

Podolsky DK. Inflammatory bowel disease. N Engl J Med.2002; 347:417-429.

Powell JJ, Murchison JT, Fearon KC, Ross JA, Siriwardena AK. Randomized controlled trial of the effect of early enteral nutrition on markers of the inflammatory response in predicted severe acute pancreatitis.Br J Surg 2000; 87: 1375–1381.

Ramirez FC, Lee K, Graham DY. All lactase preparations are not the same. results of a prospective, randomized, placebo-controlled trial. Am J Gastroenterol 1994; 89:566.

Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation. systematic review. Am J Gastroenterol 2005; 100: 936–971.

Rannem T, Ladefoged K, Hylander E, et al. Selenium status in patients with Crohn’s disease. Am J Clin Nutr. 1992; 56: 933-937.

Rao SS. Constipation. evaluation and treatment of colonic and anorectal motility disorders. Gastroenterol Clin North Am 2007; 36: 687–711.

Ravina A, Slezak L, Mirsky N, et al. Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabet Med. 1999; 16:164-167.

Reimund JM, Arondel Y, Escalin G, et al. Immune activation and nutritional status in adult Crohn’s disease patients. Dig Liver Dis. 2005; 37: 424-431.

Reimund JM, Hirth C, Koehl C, et al. Antioxidant and immune status in active Crohn’s disease: a possible relationship. Clin Nutr. 2000; 19:43-48.

Roediger WE, Duncan A, Kapaniris O, Millard S. Reducing sulfur compounds of the colon impairs colonocyte nutrition: implications for ulcerative colitis. Gastroenterology. 1993; 104:802-809.

Roediger WE, Moore J, Babidge W. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci. 1997; 42:1571-1579.

Romagnuolo J, Fedorak RN, Dias VC. Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study. Am J Gastroenterol. 2001; 96:2143-2149.

Rome Foundation. Guidelines – Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. J Gastrointestin Liver Dis 2006; 15: 307–312.

Rumessen JJ, Gudmand-Høyer E. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut 1986; 27:1161.

Rumi Jr G, Szabo I, Vincze A, et al. Decrease of serum carotenoids in Crohn’s disease. J Physiol Paris. 2000; 94:159-161.

Rydning A, Berstad A. Dietary aspects of peptic ulcer disease. Scand. J. Gastroent. 1985; 20: 29.

Saibeni S, Cattaneo M, Vecchi M, et al. Low vitamin B6 plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol. 2003; 98:112-117.

Salmon PR, Fredail SS, Wurzner HP, Harvey RF, Read AE. Effect of coffee on human lower esophageal function. Digestion 1981; 21: 69.

Sampietro GM, Cristaldi M, Cervato G, et al. Oxidative stress, vitamin A and vitamin E behaviour in patients submitted to conservative surgery for complicated Crohn’s disease. Dig Liver Dis. 2002; 34:696-701.

Sanderson IR, Croft NM. The anti-inflammatory effects of enteral nutrition. JPEN J Parenter Enteral Nutr. 2005; 29(suppl):S134-S138.

Schölmerich J. Postgastrectomy syndromes diagnosis and treatment. Best Pract Res Clin Gastroenterol 2004; 18: 917–933

Schrezenmeir J, Uttinger G, Kasper H. Die Behandlung des Dumping-Syndroms mit Guar und Acarbose. Z. Gastroent. 1983; 21; 431.

Siguel EN, Lerman RH. Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism. 1996; 45:12-23.

Simmonds NJ, Rampton SD. Inflammatory bowel disease: a radical view. Gut.1993; 34:865-868.

Simren M, Abrahamsson H, Bjornsson E. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.Gut. 2001;48:20–27.

Singh N, Makharia GK, Joshi YK. Dietary survey and total dietary fiber intake in patients with irritable bowel syndrome attending a tertiary referral hospital. Indian J Gastroenterol 2008; 27: 66–70.

Skoog SM, Bharucha AE. Dietary fructose and gastrointestinal symptoms: a review. Am J Gastroenterol 2004; 99:2046.

Spiller R, Aziz Q, Creed F et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007; 56: 1770–1798

Stenson WF, Cort D, Rodgers J, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med. 1992; 116:609-615.

Sturniolo GC, Mestriner C, Lecis PE, D’Odorico A, Venturi C, Irato P, Cecchetto A, Tropea A, Longo G, D’Inca R. Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand J Gastroenterol 1998; 33:644–649

Sturniolo GC, Montino MC, Rossetto L, Martin A, D’Inca R, D’Odorico A, Naccarato R. Inhibition of gastric acid secretion reduces zinc absorption in man. J Am Coll Nutr. 1991;10:372-5.

Sturniolo GC, Di Leo V, Ferronato A, et al. Zinc supplementation tightens “leaky gut” in Crohn’s disease. Inflamm Bowel Dis. 2001; 7:94-98.

Suarez FL, Adshead J, Furne JK, Levitt MD. Lactose maldigestion is not an impediment to the intake of 1500 mg calcium daily as dairy products. Am J Clin Nutr 1998; 68:1118.

Suchy FJ, Brannon PM, Carpenter TO, et al. National Institutes of Health Consensus Development Conference: lactose intolerance and health. Ann Intern Med 2010; 152:792.

Swagerty DL, Walling AD, Klein RM. Lactose intolerance. Am Fam Physician. 2002;65:1845–50.

Swidinski A, Vladhoff A, Pernthaler A, et al. Mucosal flares in inflammatory bowel disease. Gastroenterology. 2002; 122:44-54.

Teich N, Mössner J,Keim V: Mutations of the cationic trypsinogen in hereditary pancreatitis.Hum Mutat 1998; 12: 39–43

Teyssen S, Gonzàlez-Calero G, Schimiczek M, Singer MV: Maleic acid and succinic acid in fermented alcoholic beverages are the stimulants of gastric acid secretion. J. Clin. Invest. 1999; 103: 707–713.

Thomas FB, Steinbaugh JT, Frankes JJ, Mekhjian HS, Caldwell JH. Inhibitory effect of coffee on lower esophageal sphincter pressure. Gastroenterology 1989;79:1262.

Thurnton JR, Emmett PM, Heaton KW: Diet and Crohn’s disease. characteristics of the pre-illness diet. Br Med J. 1979; 2:762-764.

Tiengou LE, Gloro R, Pouzoulet J, et al. Semielemental formula or polymeric formula: is there a better choice for enteral nutrition in acute pancreatitis? Randomized comparative study. J Parenter Enteral Nutr 2006;30:1–5.

Trebble TM, Wootton SA, Stroud MA, et al. Laboratory markers predict bone loss in Crohn’s disease: relationship to blood mononuclear cell function and nutritional status. Aliment Pharmacol Ther. 2004; 19:1063-1071.

Troncone R, Greco L, Auricchio S. Gluten-sensitive enteropathy. Pediatr Clin North Am 1996; 43: 355–373.

Tuohy KA, Steinman TI. Hypercalcemia due to excess 1,25-dihydroxyvitamin D in Crohn’s disease. Am J Kidney Dis. 2005; 45:e3-e6.

Vakil N, SV van Zanten, P Kharilas, J Dent, R Jones, globale Konsensusgruppe. Die Montreal-Definition und -Klassifikation der gastroösophagealen Refluxkrankheit: Ein globales evidenzbasiertes Konsensus-Papier. Z. Gastroenterol. 45 (2007) 1125–1140.

Vanderhoof JA, Blackwood DJ, Mohammadpour H, Park JH. Effect of dietary menhaden oil on normal growth and development and on ameliorating mucosal injury in rats. Am J Clin Nutr. 1991; 54:346-350.

Veldhoen M, Brucklacher-Waldert V. Dietary influences on intestinal immunity. Nat Rev Immunol. 2012;12:696-708.

Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E, Brigidi P, Matteuzzi D, Campieri M. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Alim.Pharm. Therapeutics 1999; 13: 1103–1108.

Verma S, Brown S, Kirkwood B, Giaffer MH. Polymeric versus elemental diet as primary treatment in active Crohn’s disease: a randomized, double-blind trial. Am J Gastroenterol. 2000; 95:735-739.

Vogelsang H, Ferenci P, Resch H, et al. Prevention of bone mineral loss in patients with Crohn’s disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol. 1995; 7:609-614.

Vogelsang H, Ferenci P, Woloszczuk W, et al. Bone disease in vitamin D–deficient patients with Crohn’s disease. Dig Dis Sci. 1989; 34:1094-1099.

Wachtel U, Hilgarth R. Ernährung und Diätetik in Pädiatrie und Jugendmedizin, Bd II, Diätetik.Thieme, Stuttgart New York, S 100–111, 1995.

Wassermann D, Hoekstra JH, Tolia V. Molecular analysis of the fructose transporter gene(GLUT5) in isolated fructose malabsorption. J. Clin. Invest. 1996; 98: 2398–2402.

Weberhofer C. Ernährungtherapie bei Zöliakie. Aktuelle Ernaehrungsmed 2002; 27: 281–284.

Weiser HF, Pace F, Lepsien G, Müller-Lissner SA, Blum AL. Gastroösophagealer Reflux – was ist physiologisch? Dtsch. Med. Wschr. 1982;107: 366.

Woodman CL, Breen K, NoyesJr R et al. The relationship between irritable bowel syndrome and psychiatric illness. A family study. Psychosomatics 1998; 39: 45–54.

Wright JP, Mee AS, Parfitt A, et al. Vitamin A therapy in patients with Crohn’s disease. Gastroenterology. 1985; 88:512-514.

YamD, Eliraz A, Berry EM. Diet and disease — the Israeli paradox: possible dangers of a high omega-6 polyunsaturated fatty acid diet. Isr J Med Sci. 1996;32:1134–1143.

Younes-Mhenni S, Derex L, Berruyer M, et al. Large-artery stroke in a young patient with Crohn’s disease: role of vitamin B6 deficiency–induced hyperhomocysteinemia. J Neurol Sci. 2004; 221:113-115.

Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for inducing remission of Crohn’s disease. Cochrane Database Syst Rev 2001.CD000542.

Zielbauer M, Zimmer KP. Zöliakie: Mosaiksteine der Pathogenese. Aktuelle Ernaehrungsmed 2002; 27: 277–280.

Zuckerman MJ. The role of fiber in the treatment of irritable bowel syndrome: therapeutic recommendations. J Clin Gastroenterol 2006; 40: 104–108.

Pharmabrain Logo

European Union Trademark no. 006894216
US Patent and Trademark Office reg. no. 3,705,613
International Registration 1460744
All rights reserved.

Wir sind Pharmabrain.

Pharmabrain GmbH – Wir trainieren Ihren Erfolg
Gesundheitskommunikation, Teamentwicklung, Projektmanagement


Wissenschaftliche Exzellenz, praktische Orientierung, Implementierung


Unsere Enterprise Lösungen



Pharmabrain GmbH
Telefon: +49-30-28091515
E-Mail: support@pharmabrain.org

Research and Training Center

Schumannstr. 7b
D-10117 Berlin


Schumannstr. 7a
D-10117 Berlin